(Q38996872)

English

Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features

scientific article published on 11 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

M Zuberi

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

R Mir

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Das

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

I Ahmad

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Javid

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

P Yadav

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

M Masroor

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

S Ahmad

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

P C Ray

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A Saxena

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

11 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

779-787

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

https://scigraph.springernature.com/pub.10.1007/s12094-015-1303-1

0 references

New perspectives on targeted therapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The role of microRNA-200 in progression of human colorectal and breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression profiles in serous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA signatures in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNAs as regulators of epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-200-containing extracellular vesicles promote breast cancer cell metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The role of microRNAs in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Cell-free Circulating miRNA Biomarkers in Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Cost-Effectiveness of Early-Initiated Treatment for Advanced-Stage Epithelial Ovarian Cancer Patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to explain the contradiction of microRNA 200c expression and survival in solid tumors? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA in oral cancer research: future prospects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating cell-free microRNAs as biomarkers for colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-015-1303-1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38996872&oldid=1801618760"